Literature DB >> 21071957

Estimation of oxidative stress markers in chronic kidney disease.

Agnieszka Kuchta1, Anastasis Pacanis, Barbara Kortas-Stempak, Agnieszka Cwiklińska, Marcin Ziętkiewicz, Marcin Renke, Boleslaw Rutkowski.   

Abstract

Changes mediated by oxidative stress are thought to be involved with atherosclerosis in patients with chronic kidney disease (CKD). The purpose of this study was to analyze the markers of oxidative damage and the activity of antioxidative enzymes as well as the total antioxidant capability in patients with different stages of CKD, both conventionally treated and dialyzed. We evaluated the oxidative modification of lipids (by oxidized low-density lipoprotein and malonodialdehyde levels) and proteins (by advanced oxidation protein products level). We also assessed the activity of paraoxonase-1 and glutathione peroxidases and total antioxidant status. Compared with the control group, the uremic patients, both dialyzed and nondialyzed, had higher levels of all studied plasma oxidative stress markers and decreased activity of antioxidative enzymes. Our results lead us to conclude that oxidative stress seems to be related rather to the uremic state than to the dialysis treatment. We also showed that estimating total antioxidant status in a simple test is unreliable for assessing the antioxidant ability of patients with CKD.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21071957     DOI: 10.1159/000321508

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  26 in total

Review 1.  Paraoxonase 1, atherosclerosis and arterial stiffness in renal patients.

Authors:  Ozkan Gungor; Fatih Kircelli; Huseyin Toz
Journal:  Int Urol Nephrol       Date:  2012-06-06       Impact factor: 2.370

2.  Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease.

Authors:  David M Small; Kassia S Beetham; Erin J Howden; David R Briskey; David W Johnson; Nicole M Isbel; Glenda C Gobe; Jeff S Coombes
Journal:  Redox Rep       Date:  2017-01-11       Impact factor: 4.412

3.  Integrative biology identifies shared transcriptional networks in CKD.

Authors:  Sebastian Martini; Viji Nair; Benjamin J Keller; Felix Eichinger; Jennifer J Hawkins; Ann Randolph; Carsten A Böger; Crystal A Gadegbeku; Caroline S Fox; Clemens D Cohen; Matthias Kretzler
Journal:  J Am Soc Nephrol       Date:  2014-06-12       Impact factor: 10.121

Review 4.  NADPH oxidase family proteins: signaling dynamics to disease management.

Authors:  Rizwana Begum; Shilpa Thota; Abubakar Abdulkadir; Gagandeep Kaur; Prathyusha Bagam; Sanjay Batra
Journal:  Cell Mol Immunol       Date:  2022-05-18       Impact factor: 22.096

5.  CKD Increases Carbonylation of HDL and Is Associated with Impaired Antiaggregant Properties.

Authors:  Nans Florens; Catherine Calzada; Sandrine Lemoine; Marie Michèle Boulet; Nicolas Guillot; Christophe Barba; Julie Roux; Fréderic Delolme; Adeline Page; Jean Michel Poux; Maurice Laville; Philippe Moulin; Laurent Soulère; Fitsum Guebre-Egziabher; Laurent Juillard; Christophe O Soulage
Journal:  J Am Soc Nephrol       Date:  2020-06-09       Impact factor: 10.121

Review 6.  Linking chronic kidney disease and Parkinson's disease: a literature review.

Authors:  Jesús D Meléndez-Flores; Ingrid Estrada-Bellmann
Journal:  Metab Brain Dis       Date:  2020-09-29       Impact factor: 3.584

Review 7.  Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.

Authors:  Sandra Merscher; Christopher E Pedigo; Armando J Mendez
Journal:  Front Endocrinol (Lausanne)       Date:  2014-10-14       Impact factor: 5.555

Review 8.  Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease.

Authors:  Simona Granata; Alessandra Dalla Gassa; Gloria Bellin; Antonio Lupo; Gianluigi Zaza
Journal:  Biomed Res Int       Date:  2016-06-21       Impact factor: 3.411

9.  Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress.

Authors:  Catherine K Yeung; Frederic T Billings; Adam J Claessens; Baback Roshanravan; Lori Linke; Mary B Sundell; Suhail Ahmad; Baohai Shao; Danny D Shen; T Alp Ikizler; Jonathan Himmelfarb
Journal:  BMC Nephrol       Date:  2015-11-03       Impact factor: 2.388

Review 10.  Mitochondria: a new therapeutic target in chronic kidney disease.

Authors:  Simona Granata; Alessandra Dalla Gassa; Paola Tomei; Antonio Lupo; Gianluigi Zaza
Journal:  Nutr Metab (Lond)       Date:  2015-11-25       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.